Bryce Point Capital LLC Takes $586,000 Position in ICU Medical, Inc. $ICUI

Bryce Point Capital LLC bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,886 shares of the medical instruments supplier’s stock, valued at approximately $586,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ICUI. Arizona State Retirement System grew its holdings in ICU Medical by 1.3% in the 3rd quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock worth $828,000 after acquiring an additional 91 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of ICU Medical by 11.6% during the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares during the period. BNP Paribas Financial Markets grew its stake in shares of ICU Medical by 4.5% in the second quarter. BNP Paribas Financial Markets now owns 2,459 shares of the medical instruments supplier’s stock worth $325,000 after purchasing an additional 107 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in ICU Medical by 0.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 18,098 shares of the medical instruments supplier’s stock valued at $2,392,000 after purchasing an additional 114 shares during the period. Finally, Maryland State Retirement & Pension System raised its position in ICU Medical by 1.8% during the 2nd quarter. Maryland State Retirement & Pension System now owns 7,233 shares of the medical instruments supplier’s stock valued at $956,000 after purchasing an additional 129 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Price Performance

Shares of NASDAQ ICUI opened at $151.86 on Tuesday. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $165.17. The company has a 50 day moving average of $148.71 and a 200 day moving average of $134.66. The company has a quick ratio of 1.19, a current ratio of 2.45 and a debt-to-equity ratio of 0.62. The firm has a market cap of $3.75 billion, a P/E ratio of -489.86 and a beta of 0.79.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ICUI. KeyCorp boosted their price target on shares of ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. Wall Street Zen downgraded ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Piper Sandler raised their target price on ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $175.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.